Authors: Wandi Abbas1, Tria Anggita Umayana2 1Master Program of International Relations, Airlangga University; University of West Sulawesi, Indonesia 2Master Program of International Relatio... Read more
Authors: 1Vina Fitria Yon Surya, 2Erma Sulistyaningsih, & 3Zarah Puspitaningtyas Master Program of Public Health Sciences, Graduate program, University of Jember Abstract Quality of serv... Read more
Authors: widiyanti Afifah1, Ana Nurlaili Hidayat2, Nurul Ma’rifah3, Retno Nurhayati 1,2 ,3Master of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, 4Aisyiyah Bojonegoro Hospita... Read more
Authors: Moch Rizal Ardiansyah, Yulistiani* Departement of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University 60286, Surabaya, Indonesia E-mail: yulist_r@yahoo.co.id Abstract Alzhe... Read more
Authors: Rizal, Diah Sri E, Devi Oktafia, Didik Hasmono Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya,East Java, Indonesia email: rizal.alzanzhy@gmail.... Read more
Authors: Ayu Visita Dwi*, Didik Hasmono Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Dharmawangsa Dalam, 60286 Surabaya, Indonesia *E-mail : ayuvisita@yahoo.co... Read more
Authors:Maria Lettisia Meo1, Didik Hasmono2
Department of Clinical Pharmacy, Faculty of Pharmacy,
Airlangga University, Surabaya, Indonesia
E-mail: gwae23@gmail.com
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease, exceeded only by Alzheimer’s disease (AD). Psychosis can be a major problem in Parkinson’s disease. Psychosis is a frequent complication of PD, and it is characterized mainly by visual hallucinations and delusions, which are often paranoid in flavor. Psychotic symptoms are present in up to 50% of patients with Parkinson’s disease. These symptoms have detrimental effects on patients’ and caregivers’ quality of life and may predict mortality. Psychosis (hallucinations and delusions) occurring in the context of Parkinson’s disease may be primary, reflecting a progression of the underlying disease process, or secondary to the use of dopaminomimetic drugs. Attempts to reduce dopaminomimetic drugs or the initiation of antipsychotics can exacerbate motor symptoms in Parkinson’s disease with psychosis (hallucinations and dellusions). Psychosis in Parkinson’s disease (PDP) often responds to low doses of atypical neuroleptics but adverse event but the side effects and safety of each drugs should still be observe. Therefore the selection of appropriate therapy is expected to improve the quality of life of psychosis patients with Parkinson’s disease
Keywords: Antipsichosis, Parkinson Desease, Psychosis
Authors: Lucky Argasetya, Didik Hasmono, Suharjono Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University Jalan Dharmawangsa Dalam, Surabaya 60286, East Java, Indonesia e... Read more
Authors: Herni Setyawati1, Yulistiani2,3 1Magister Farmasi Klinik, Fakultas Farmasi Universitas Airlangga, Surabaya, Indonesia, 2Departemen Farmasi Klinik, Fakultas Farmasi Universitas Airl... Read more
Authors: Ana Nurlaili Hidayah1, Nurul Ma’rifah2, Widyanti Afifah3, Didik Hasmono4 1Master Program of Clinical Pharmacy, 3Master Program of Clinical Pharmacy, 4Faculty of Pharmacy, Airlangga... Read more
